Observational Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Nov 6, 2022; 10(31): 11411-11418
Published online Nov 6, 2022. doi: 10.12998/wjcc.v10.i31.11411
Table 4 Seropositivity rates of cancer patients after severe acute respiratory syndrome coronavirus 2 vaccination according to treatment status
Characteristic
Seropositivity
No therapy94.1% (43/51)
Targeted therapy83.3% (30/36)
Immunotherapy74.1% (20/27)
Chemotherapy66.7% (12/18)